Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacob Levitt

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
Journal of the American Academy of Dermatology|May 1, 2007
The safety of hydroquinone: a dermatologist's response to the 2006 Federal RegisterJacob Levitt
Journal of the American Academy of Dermatology|November 29, 2005
Medical pearl: Sarcoidosis prognosisJacob Levitt
Archives of Disease in Childhood. Education and Practice Edition|April 13, 2011
Oral Ivermectin is more effective than topical malathion in difficult-to-treat head lice infestationJacob Levitt
Dermatology Online Journal|November 7, 2006
A case of oral lichen planus with Good syndromeMargarita Lolis, Jacob Levitt
Journal of Drugs in Dermatology : JDD|August 12, 2009
Malathion for head lice and scabies: treatment and safety considerationsShereene Idriss, Jacob Levitt
JAMA|October 8, 2014
Intensely pruritic eruption in a college studentShira Wieder, Jacob Levitt
JAAD Case Reports|February 2, 2018
Alopecia areata after dupilumab for atopic dermatitisKrystal Mitchell, Jacob Levitt
Clinical Therapeutics|April 15, 2008
Assessing retinol stability in a hydroquinone 4%/retinol 0.3% cream in the presence of antioxidants and sunscreen under simulated-use conditions: a pilot studyArash Akhavan, Jacob Levitt
JAAD Case Reports|August 2, 2021
Skin necrosis at both COVID-19 vaccine injection sitesDiana Gruenstein, Jacob Levitt
Journal of Drugs in Dermatology : JDD|April 25, 2012
Where does rituximab fit in the treatment of autoimmune mucocutaneous blistering skin disease?Rishi Nigam, Jacob Levitt
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
Journal of the American Academy of Dermatology|May 1, 2007
The safety of hydroquinone: a dermatologist's response to the 2006 Federal RegisterJacob Levitt
Journal of the American Academy of Dermatology|November 29, 2005
Medical pearl: Sarcoidosis prognosisJacob Levitt
Archives of Disease in Childhood. Education and Practice Edition|April 13, 2011
Oral Ivermectin is more effective than topical malathion in difficult-to-treat head lice infestationJacob Levitt
Dermatology Online Journal|November 7, 2006
A case of oral lichen planus with Good syndromeMargarita Lolis, Jacob Levitt
Journal of Drugs in Dermatology : JDD|August 12, 2009
Malathion for head lice and scabies: treatment and safety considerationsShereene Idriss, Jacob Levitt
JAMA|October 8, 2014
Intensely pruritic eruption in a college studentShira Wieder, Jacob Levitt
JAAD Case Reports|February 2, 2018
Alopecia areata after dupilumab for atopic dermatitisKrystal Mitchell, Jacob Levitt
Clinical Therapeutics|April 15, 2008
Assessing retinol stability in a hydroquinone 4%/retinol 0.3% cream in the presence of antioxidants and sunscreen under simulated-use conditions: a pilot studyArash Akhavan, Jacob Levitt
JAAD Case Reports|August 2, 2021
Skin necrosis at both COVID-19 vaccine injection sitesDiana Gruenstein, Jacob Levitt
Journal of Drugs in Dermatology : JDD|April 25, 2012
Where does rituximab fit in the treatment of autoimmune mucocutaneous blistering skin disease?Rishi Nigam, Jacob Levitt
Pageof 7